Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1183/13993003.00858-2020

http://scihub22266oqcxt.onion/10.1183/13993003.00858-2020
suck pdf from google scholar
32265310!7144273!32265310
unlimited free pdf from europmc32265310    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32265310      Eur+Respir+J 2020 ; 55 (6): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 #MMPMID32265310
  • Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
  • Eur Respir J 2020[Jun]; 55 (6): ä PMID32265310show ga
  • The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily using mesenchymal stem (stromal) cells (MSCs), have demonstrated safety and possible efficacy in patients with acute respiratory distress syndrome (ARDS), although they are not yet well studied in respiratory virus-induced ARDS. Limited pre-clinical data suggest that systemic MSC administration can significantly reduce respiratory virus (influenza strains H5N1 and H9N2)-induced lung injury; however, there are no available data in models of coronavirus respiratory infection.There is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To provide a rational strategy to maximise potential therapeutic use, it is critically important to understand the relevant pre-clinical studies and postulated mechanisms of MSC actions in respiratory virus-induced lung injuries. This review presents these, along with consideration of current clinical investigations.
  • |*Culture Media, Conditioned[MESH]
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Animals[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |Cell- and Tissue-Based Therapy[MESH]
  • |Coronavirus Infections/*therapy[MESH]
  • |Extracellular Vesicles/transplantation[MESH]
  • |Humans[MESH]
  • |Influenza A Virus, H5N1 Subtype[MESH]
  • |Influenza A Virus, H9N2 Subtype[MESH]
  • |Influenza, Human/*therapy[MESH]
  • |Lung Injury/*therapy/virology[MESH]
  • |Mesenchymal Stem Cell Transplantation/*methods[MESH]
  • |Mesenchymal Stem Cells/metabolism[MESH]
  • |Orthomyxoviridae Infections/therapy[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Pneumonia, Viral/*therapy[MESH]
  • |Respiratory Distress Syndrome/*therapy[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box